RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib
2019-01-01 Leppa, S; Santoro, A; Demeter, J; Follows, G; Lenz, G; Kim, Ws; Mollica, L; Nagler, A; Diong, Cp; Provencio, M; Stevens, Da; Trevarthen, Dr; Wang, Ml; Wirtz, O; Miriyala, A; Vargas, Jg; Childs, Bh; Zinzani, Pl; Dreyling, Mh
Malignant pleural mesothelioma (MPM) evaluation with C-11-methionine PET/CT before and after talc pleurodesis
2017-01-01 Lopci, E; Zucali, P; Ceresoli, G; Testori, A; Emanuele, V; Bottoni, E; Marzo, K; Leonardi, L; Rodari, M; Ferraroli, G; Crepaldi, A; Veronesi, G; Alloisio, M; Santoro, A; Chiti, A
Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy and medical treatment in 60 patients
2009-01-01 Incarbone, M; Ceresoli, Gl; Bottoni, E; Voulaz, E; Morenghi, E; Zucali, Pa; Gianoncelli, L; Testori, A; Ravasi, G; Scorsetti, M; Santoro, A; Alloisio, M
Newly diagnoses grade III glioma patients: evaluation of factors conditioning outcome
2017-01-01 Navarria, P; Pessina, F; Tomatis, S; Cozzi, L; D'Agostino, Gr; Ascolese, Am; Simonelli, M; Santoro, A; Clerici, E; Franzese, C; Bello, L; Scorsetti, M
Nurses and health care assistants: Evaluation of attitude towards the care of patients who are terminally ill with cancer.
2018-01-01 Lopane, D; Pavesi, C; Arcana, C; Morazzoni, G; Lopane, D; Ferrari, S; Giuffre, S; Poggio, C; Banfi, D; Lamiani, G; Saetta, A; Rimassa, L; Santoro, A
Oncofid-P-B for the treatment of BCG unresponsive carcinoma in situ (CIS) of bladder: Results of European multicenter phase I study at the end of 12- consecutive weeks intensive course
2020-01-01 Hurle, R; Guazzoni, Gf; Colombo, P; Santoro, A; De Cobelli, O; Di Trapani, E; Nohales, G; Carlos, L; Duran-Merino, R; Lazzeri, M
ONCOFID-PB FOR THE TREATMENT OF BCG UNRESPONSIVE CARCINOMA IN SITU (CIS) OF BLADDER: PRELIMINARY RESULTS OF EUROPEAN MULTICENTRE PHASE 1 STUDY AT THE END OF 12 CONSECUTIVE WEEKS INTENSIVE COURSE AND DURING ONGOING MONTHLY MAINTENANCE PHASE
2020-01-01 Hurle, R; Guazzoni, G; Colombo, P; Santoro, A; De Cobelli, O; Di Trapani, E; Nohales, G; Llorente, G; Duran-Merino, R; Lazzeri, M
Optimizing residual surgery for patients with primary extragonadal germ cell tumors
2006-01-01 Simonelli, M; Banna, Gl; De Giorgi, U; Ferrari, B; Alloisio, M; Incarbone, M; Chiti, A; Rosti, G; Santoro, A
Outcome of high-grade gliomas (HGGs) treated into immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience
2019-01-01 Simonelli, M; Persico, P; Dipasquale, A; Lorenzi, E; Giordano, L; Pessina, F; Navarria, P; Scorsetti, M; Bello, L; Santoro, A
Parametrical analyses at baseline and interim PET for response assessment and outcome definition in patients affected by malignant pleural mesothelioma (MPM)
2014-01-01 Lopci, E; Zucali, P; Perrino, M; Giordano, L; Ceresoli, G; Alloisio, M; Rodari, M; Lorenzi, E; Santoro, A; Chiti, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib | 1-gen-2019 | Leppa, S; Santoro, A; Demeter, J; Follows, G; Lenz, G; Kim, Ws; Mollica, L; Nagler, A; Diong, Cp; Provencio, M; Stevens, Da; Trevarthen, Dr; Wang, Ml; Wirtz, O; Miriyala, A; Vargas, Jg; Childs, Bh; Zinzani, Pl; Dreyling, Mh | |
Malignant pleural mesothelioma (MPM) evaluation with C-11-methionine PET/CT before and after talc pleurodesis | 1-gen-2017 | Lopci, E; Zucali, P; Ceresoli, G; Testori, A; Emanuele, V; Bottoni, E; Marzo, K; Leonardi, L; Rodari, M; Ferraroli, G; Crepaldi, A; Veronesi, G; Alloisio, M; Santoro, A; Chiti, A | |
Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy and medical treatment in 60 patients | 1-gen-2009 | Incarbone, M; Ceresoli, Gl; Bottoni, E; Voulaz, E; Morenghi, E; Zucali, Pa; Gianoncelli, L; Testori, A; Ravasi, G; Scorsetti, M; Santoro, A; Alloisio, M | |
Newly diagnoses grade III glioma patients: evaluation of factors conditioning outcome | 1-gen-2017 | Navarria, P; Pessina, F; Tomatis, S; Cozzi, L; D'Agostino, Gr; Ascolese, Am; Simonelli, M; Santoro, A; Clerici, E; Franzese, C; Bello, L; Scorsetti, M | |
Nurses and health care assistants: Evaluation of attitude towards the care of patients who are terminally ill with cancer. | 1-gen-2018 | Lopane, D; Pavesi, C; Arcana, C; Morazzoni, G; Lopane, D; Ferrari, S; Giuffre, S; Poggio, C; Banfi, D; Lamiani, G; Saetta, A; Rimassa, L; Santoro, A | |
Oncofid-P-B for the treatment of BCG unresponsive carcinoma in situ (CIS) of bladder: Results of European multicenter phase I study at the end of 12- consecutive weeks intensive course | 1-gen-2020 | Hurle, R; Guazzoni, Gf; Colombo, P; Santoro, A; De Cobelli, O; Di Trapani, E; Nohales, G; Carlos, L; Duran-Merino, R; Lazzeri, M | |
ONCOFID-PB FOR THE TREATMENT OF BCG UNRESPONSIVE CARCINOMA IN SITU (CIS) OF BLADDER: PRELIMINARY RESULTS OF EUROPEAN MULTICENTRE PHASE 1 STUDY AT THE END OF 12 CONSECUTIVE WEEKS INTENSIVE COURSE AND DURING ONGOING MONTHLY MAINTENANCE PHASE | 1-gen-2020 | Hurle, R; Guazzoni, G; Colombo, P; Santoro, A; De Cobelli, O; Di Trapani, E; Nohales, G; Llorente, G; Duran-Merino, R; Lazzeri, M | |
Optimizing residual surgery for patients with primary extragonadal germ cell tumors | 1-gen-2006 | Simonelli, M; Banna, Gl; De Giorgi, U; Ferrari, B; Alloisio, M; Incarbone, M; Chiti, A; Rosti, G; Santoro, A | |
Outcome of high-grade gliomas (HGGs) treated into immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience | 1-gen-2019 | Simonelli, M; Persico, P; Dipasquale, A; Lorenzi, E; Giordano, L; Pessina, F; Navarria, P; Scorsetti, M; Bello, L; Santoro, A | |
Parametrical analyses at baseline and interim PET for response assessment and outcome definition in patients affected by malignant pleural mesothelioma (MPM) | 1-gen-2014 | Lopci, E; Zucali, P; Perrino, M; Giordano, L; Ceresoli, G; Alloisio, M; Rodari, M; Lorenzi, E; Santoro, A; Chiti, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 84
- 1 Contributo su Rivista::1.5 Abst... 84
Data di pubblicazione
- 2020 - 2022 8
- 2010 - 2019 52
- 2003 - 2009 24
Rivista
- ANNALS OF ONCOLOGY 21
- JOURNAL OF CLINICAL ONCOLOGY 17
- BLOOD 6
- INTERNATIONAL JOURNAL OF RADIATIO... 4
- JOURNAL OF THORACIC ONCOLOGY 4
- BONE MARROW TRANSPLANTATION 3
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 3
- RADIOTHERAPY AND ONCOLOGY 3
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 2
- HAEMATOLOGICA 2
Keyword
- Dabrafenib 1
- Immune-mediated event 1
- Melanoma 1
- Sarcoidosis 1
- Targeted therapy 1
- Trametinib 1
Lingua
- eng 30
Accesso al fulltext
- no fulltext 80
- reserved 4